UnknownPhase 3

Oral Colostrum and Its Effect on Immune System

Mexico96 participantsStarted 2018-06-01

Plain-language summary

The purpose of this project is to increase the serum immunological defenses of premature infants less then 32 weeks of gestation by administrating colostrum in the oropharyngeal mucosa versus placebo

Who can participate

Age range12 Hours – 36 Hours

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * NEWBORN 32 Gestational weeks * Hospitalized in neonatal intensive care Unit * Agreement signed by the legal representative Exclusion Criteria: * Intraventricular haemorrhage II/IV grade * Congenital sepsis (early sepsis) * Congenital malformations * Early transfusions

What they're measuring

Quantification of serum Immunoglobulins

Timeframe: From baseline to day 7

Trial details

NCT IDNCT03578341

SponsorInstituto Nacional de Perinatologia Isidro Espinosa de los Reyes

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2019-10-30

View on ClinicalTrials.gov More Immune System Diseases trials